Forget Moderna! This Is a Stronger Coronavirus Stock
Pfizer, BioNTech , and Moderna (NASDAQ: MRNA) have seen their shares rise over the past few months because of their work to develop vaccines against COVID-19. Moderna, which started off the year with a share price of $19.50 has seen its stock climb more than 608% year to date to $138.
CVS Health (NYSE: CVS) is probably not the first company you think of when you think of a "coronavirus" stock, but it will be one in 2021, and unlike Moderna, it's long been profitable.
Image source: Getty Images.
Source Fool.com
